Osaic Holdings
TVTX icon

Osaic Holdings’s Travere Therapeutics TVTX Stock Holding History

Osaic Holdings’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Buy
2,160
+799
+59% +$35.4K ﹤0.01% 4792
2026
Q1 		$40.4K Sell
1,361
-6,518
-83% -$195K ﹤0.01% 5371
2025
Q4 		$301K Buy
7,879
+7,758
+6,412% +$252K ﹤0.01% 3811
2025
Q3 		$2.66K Buy
121
+68
+128% +$1.28K ﹤0.01% 7044
2025
Q2 		$784 Buy
53
+30
+130% +$497 ﹤0.01% 7232
2025
Q1 		$412 Sell
23
-54
-70% -$1.1K ﹤0.01% 7041
2024
Q4 		$1.34K Sell
77
-47
-38% -$831 ﹤0.01% 6746
2024
Q3 		$1.73K Hold
124
– – ﹤0.01% 6671
2024
Q2 		$1.02K Buy
124
+101
+439% +$680 ﹤0.01% 6810
2024
Q1 		$177 Hold
23
– – ﹤0.01% 6971
2023
Q4 		$206 Hold
23
– – ﹤0.01% 7038
2023
Q3 		$205 Sell
23
-1,476
-98% -$20.8K ﹤0.01% 7151
2023
Q2 		$23K Buy
1,499
+402
+37% +$7.31K ﹤0.01% 5469
2023
Q1 		$24.7K Buy
1,097
+55
+5% +$1.17K ﹤0.01% 5447
2022
Q4 		$21.1K Sell
1,042
-108
-9% -$2.29K ﹤0.01% 5520
2022
Q3 		$29K Buy
1,150
+45
+4% +$1.16K ﹤0.01% 5327
2022
Q2 		$27K Sell
1,105
-164
-13% -$4.12K ﹤0.01% 5410
2022
Q1 		$33K Buy
1,269
+110
+9% +$2.92K ﹤0.01% 5389
2021
Q4 		$36K Sell
1,159
-2
-0.2% -$56 ﹤0.01% 5393
2021
Q3 		$28K Buy
1,161
+1,086
+1,448% +$20K ﹤0.01% 5538
2021
Q2 		$1K Hold
75
– – ﹤0.01% 6892
2021
Q1 		$2K Hold
75
– – ﹤0.01% 6526
2020
Q4 		$2K Hold
75
– – ﹤0.01% 6115
2020
Q3 		$1K Hold
75
– – ﹤0.01% 6082
2020
Q2 		$2K Sell
75
-450
-86% -$7.17K ﹤0.01% 5832
2020
Q1 		$8K Buy
+525
New +$7.9K ﹤0.01% 5144

Other funds holding TVTX

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Osaic Holdings's TVTX Position: Q2 2026 in Review

Osaic Holdings increased its Travere Therapeutics (TVTX) stake by 59% in Q2 2026, buying an estimated $35.4K and bringing the position to 2,160 shares worth $123K. The position accounts for ﹤0.01% of the portfolio, ranked #4792.

Osaic Holdings first reported a position in TVTX in Q1 2020 and has held it in 26 quarters since. The position peaked at $301K in Q4 2025. 320 funds tracked by Wall St. Rank hold TVTX as of Q2 2026.

  • Osaic Holdings held 2,160 shares of Travere Therapeutics worth $123K as of Q2 2026.
  • Osaic Holdings bought 799 Travere Therapeutics shares in Q2 2026, an estimated $35.4K.
  • Travere Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #4792 holding.
  • Osaic Holdings first reported a position in Travere Therapeutics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Travere Therapeutics position peaked at $301K in Q4 2025.
  • 320 funds tracked by Wall St. Rank held Travere Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.